Cinematherapy for Women With Depression and Anxiety

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 17, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Cinematherapy for Women With Depression and Anxiety," is exploring how watching movies in a group setting can help reduce feelings of sadness and anxiety in women diagnosed with depression and anxiety disorders. The program aims to see if this fun and engaging approach can improve mental health for women between the ages of 18 and 75 who are currently taking medication for their conditions.

To participate in this study, women must have a diagnosis of either unipolar or bipolar depression and anxiety disorders, and they should be fluent in Italian. They also need to agree to be part of the study by signing a consent form. Unfortunately, women with certain serious mental health conditions, such as schizophrenia, or those who are currently struggling with substance abuse, cannot take part in this trial. Participants can expect to engage in group movie-watching sessions and share their experiences, which may help them feel better and connect with others facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • female, aged 18-75 years;
• • Diagnosis of Depressive Disorders (unipolar and bipolar) and Anxiety Disorders according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5), both new onset in subjects without a previous psychiatric history, and depressive and anxious recurrences;
• • Taking psychopharmacological therapy;
• • Fluent knowledge of the Italian language;
• • Release of a written informed consent, signed by the patient or legal representative and partner.
• Exclusion Criteria:
• • Diagnosis of Schizophrenia or other psychotic spectrum disorders;
• • Diagnosis of neurological disorders associated with cognitive decline;
• • Current abuse of alcohol and psychotropic substances, with the exception of smoking;
• • Refusal to sign the informed consent to participate in the study.